Phio Pharmaceuticals to present at NIBA 153rd Conference, updates PH-762 program
Bitget2026/10/05 11:09Phio Pharmaceuticals will present at NIBA’s 153rd Conference in Fort Lauderdale, Florida, on Oct. 6-7, 2026. CEO Robert Bitterman is scheduled to present on Oct. 7, 2026 at 12:40 p.m. EDT. Talk will cover the INTASYL siRNA platform, delivery approach, strategic direction, with a development update on PH-762 in cutaneous squamous cell carcinoma. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610050700NEWSFILECNPR____20261005_317275_1) on October 05, 2026, and is solely responsible for the information contained therein.
- Phio Pharmaceuticals will present at NIBA’s 153rd Conference in Fort Lauderdale, Florida, on Oct. 6-7, 2026.
- CEO Robert Bitterman is scheduled to present on Oct. 7, 2026 at 12:40 p.m. EDT.
- Talk will cover the INTASYL siRNA platform, delivery approach, strategic direction, with a development update on PH-762 in cutaneous squamous cell carcinoma.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Michael Saylor releases bitcoin Tracker information again, possibly hinting at increasing BTC holdings
Crypto Pundit Says If You Are Holding XLM, Read This
Only 1.45 Billion Shiba Inu (SHIB) Burned in 24 Hours Hints at Reversal
Crypto prices
More
